[Therapeutic examination of proscillaridin A].
D002301:Cardiac Glycosides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004304:Dosage Forms; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans
D002301:Cardiac Glycosides; D004304:Dosage Forms
Therapeutische Prüfung von Proscillaridin A.